Výsledky vyhledávání

The impact of statin on post-operative atrial fibrillation after discharge from cardiac surgery: secondary analysis of the SEARCH-AF CardioLink-1 randomized trial

Autor: M Hibibo, S Verma, A Pandey, A Quan, A Verma, G Bisleri, A Ha, C D Mazer

Publikováno v: European Heart Journal. 43

Background There is conflicting evidence regarding the use of statins to reduce the risk of post-operative atrial fibrillation (POAF) in patients undergoing cardiac surgery. Purpose We sought to determine the effects of statin use on the burden of ne

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a05959f456ada657630dbb7e56ab0b41
https://doi.org/10.1093/eurheartj/ehac544.2342

Zobrazit plný text záznamu

Valvular surgery is associated with an increased risk of post-operative atrial fibrillation: secondary analysis of the SEARCH-AF CardioLink-1 randomized trial

Autor: M Hibino, S Verma, A Pandey, A Quan, A Verma, G Bisleri, C D Mazer, A Ha

Publikováno v: European Heart Journal. 43

Background Patients undergoing valve surgery have a higher risk of developing post-operative atrial fibrillation (POAF) relative to those undergoing isolated coronary artery bypass grafting (CABG). Whether this risk extends beyond hospital discharge

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c16ae38ad678ec34b728e55631afc58c
https://doi.org/10.1093/eurheartj/ehac544.2163

Zobrazit plný text záznamu

Impact of polyvascular disease and renal dysfunction on cardiovascular outcomes in diabetes: post hoc analyses from EMPA-REG OUTCOME

Autor: Anne Pernille Ofstad, C Wanner, Bernard Zinman, Silvio E. Inzucchi, C D Mazer, Isabella Zwiener, OE Johansen, Javed Butler, Jyothis T. George, Subodh Verma

Publikováno v: European Heart Journal. 41

Background Individuals with polyvascular disease and impaired renal function are at high risk of cardiovascular (CV) events, but this relationship is not well investigated in people with type 2 diabetes (T2D). Furthermore, the impact of polyvascular

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::11a2bf79071e22b9f05884f644024a90
https://doi.org/10.1093/ehjci/ehaa946.3352

Zobrazit plný text záznamu

A randomized surgical trial of mitral valve repair with leaflet resection versus leaflet preservation on functional mitral stenosis – primary results of the CAMRA CardioLink-2 trial

Autor: C D Mazer, Thierry G. Mesana, D.A Latter, Denis Bouchard, Adrian Quan, Peter Jüni, Alexander J. Gregory, F Mohamad Ali, W Tsang, Fei Zuo, H Leong-Poi, Subodh Verma, Vincent Chan, Hwee Teoh, B. de Varennes

Publikováno v: European Heart Journal. 41

Background The gold standard treatment for mitral valve regurgitation due to prolapse involves surgery with annuloplasty and either leaflet resection or leaflet preservation, with placement of artificial neochordae. It has been suggested that leaflet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1dbc6001a18fc59fc843298fe1cd1360
https://doi.org/10.1093/ehjci/ehaa946.1980

Zobrazit plný text záznamu

P3753Does empagliflozin modulate the autonomic system among patients with type 2 diabetes and coronary artery disease? Insights from the Holter sub-study of the EMPA-Heart CardioLink-6 Randomised Trial

Autor: V Garg, Paul Dorian, Peter Jüni, B Zinman, Kim A. Connelly, Andrew T. Yan, C D Mazer, Andrew C.T. Ha, Lawrence A. Leiter, Amit X. Garg, A Sikand, Subodh Verma, Adrian Quan, Amit Verma, Fei Zuo

Publikováno v: European Heart Journal. 40

Introduction The mechanism behind how empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, reduces all-cause and cardiovascular mortality among patients with type 2 diabetes (T2DM) and coronary artery disease (CAD) is unknown. Autonomi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7af753b7df40e396bffc5faba332083b
https://doi.org/10.1093/eurheartj/ehz745.0605

Zobrazit plný text záznamu

P5602Comparison of innominate vs axillary artery cannulation for cerebral protection on neurocognitive outcomes in aortic surgery: a pre-specified analysis of the ACE CardioLink-3 randomised trial

Autor: C D Mazer, Michael W.A. Chu, V Garg, Adrian Quan, M D Peterson, Fei Zuo, Hwee Teoh, Subodh Verma, Eric E. Smith

Publikováno v: European Heart Journal. 40

Background Success after aortic surgery depends on avoidance of neurocognitive dysfunction, thus novel adjuncts to proximal aortic surgery must be evaluated for efficacy of cerebral protection during circulatory arrest. We report the primary neurocog

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b66cf6d3551f3ef4b4de5c5769481490
https://doi.org/10.1093/eurheartj/ehz746.0546

Zobrazit plný text záznamu

56The SGLT2 inhibitor empagliflozin reduces mortality in experimental pulmonary hypertension

Autor: Yi Pan, V. Luu, M G Kabir, A. Luu, Subodh Verma, C D Mazer, Adrian Quan, B Chowdhury, Hwee Teoh

Publikováno v: European Heart Journal. 40

Introduction Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, enhances urinary glucose excretion and profoundly reduces hospitalisation for heart failure and cardiovascular mortality in individuals with type 2 diabetes. While empag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e290ad86ad8d43ee6c8b9f56d9b4cf95
https://doi.org/10.1093/eurheartj/ehz747.0009

Zobrazit plný text záznamu

P317A novel role of SGLT2 inhibitors to increase circulating proangiogenic progenitor cells in patients with type 2 diabetes and cardiovascular disease: A sub-study of the EMPA-HEART CardioLink-6 Trial

Autor: T. Mason, D. Terenzi, J Z Trac, B Zinman, Natasha Dhingra, Kim A. Connelly, Subodh Verma, Adrian Quan, Lawrence A. Leiter, Andrew T. Yan, C D Mazer, Hwee Teoh, M Al-Omran, David A. Hess

Publikováno v: European Heart Journal. 40

Background SGLT2 inhibitors (SGLT2i) have been demonstrated to reduce major adverse cardiovascular events and mortality in patients with type 2 diabetes (T2D) who are at high risk for cardiovascular disease (CVD). However, the mechanism(s) of the und

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8a8fb9b8162118e0b5ea9f1261cadb56
https://doi.org/10.1093/eurheartj/ehz747.0152

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání